Concepedia

I. Tsibulak

IT

Statistics

Publications

1

Citations

15

H-Index

1

Active since

2022

Affiliations

Institut de Cancérologie Strasbourg(Current)

I. Tsibulak is an author at Institut de Cancérologie Strasbourg specializing in ovarian cancer clinical trials, adjuvant chemotherapy, and atezolizumab therapy.

Publications per year

2022–2022

1

Publications

1

LBA30 Phase III ATALANTE/ov29 trial: Atezolizumab (Atz) versus placebo with platinum-based chemotherapy (Cx) plus bevacizumab (bev) in patients (pts) with platinum-sensitive relapse (PSR) of epithelial ovarian cancer (OC)

J.E. Kurtz, E. Pujade-Lauraine, A. Oaknin et al. · Annals of Oncology · 2022 · 15 citations

Medicine, Oncology, Pharmacology +17

1–1 of 1